Posts

Trump Announces Up to 100% Tariffs on Imported Patented Drugs

on

UK Agrees to Increase Drug Spending by 25% to Avoid US Pharma Tariffs

on

Trump Administration Pauses Pharmaceutical Tariffs to Negotiate Industry Agreements

on

Trump Administration May Exempt Some Pharma Products from Future Tariffs in Trade Policy Shift

on

Eli Lilly Endorses Trump's Goal by Raising Drug Prices Abroad to Align with U.S. Levels

on

Teva Execs Shrug Off Pharmaceutical Tariff Threat as Turnaround Strategy Rolls Forward

on

Trump's Pharmaceutical Tariffs Materialize in New US-EU Trade Deal

on

Trump Threatens 200% Tariffs on Pharma Imports, Proposes 1-Year Grace Period for Onshoring

on

'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge

on

Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies

on

U.S. Biotechs Reveal Tariff Exposure as Trade Inquiry Signals Imminent Pharmaceutical Tariffs

on

Global Pharmaceutical Stocks Plummet Amid Trump's Imminent Tariff Threats

on

Trump Announces Imminent Major Tariffs on Pharmaceuticals: Implications for Global Markets and U.S. Manufacturing

on

Trump's Looming Pharmaceutical Tariffs: Uncertainty and Potential Impact

on